Proof-of-Principle Evaluation of the Efficacy of Fewer Than Three Doses of a Bivalent HPV16/18 Vaccine

BACKGROUND: Three-dose regimens for human papillomavirus (HPV) vaccines are expensive and difficult to complete, especially in settings where the need for cervical cancer prevention is greatest. METHODS: We evaluated the vaccine efficacy of fewer than three doses of the HPV16/18 vaccine Cervarix in...

Descripción completa

Detalles Bibliográficos
Autores principales: Kreimer, Aimée R., Rodriguez, Ana Cecilia, Hildesheim, Allan, Herrero, Rolando, Porras, Carolina, Schiffman, Mark, González, Paula, Solomon, Diane, Jiménez, Silvia, Schiller, John T., Lowy, Douglas R., Quint, Wim, Sherman, Mark E., Schussler, John, Wacholder, Sholom
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2011
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3186781/
https://www.ncbi.nlm.nih.gov/pubmed/21908768
http://dx.doi.org/10.1093/jnci/djr319

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3186781/
https://www.ncbi.nlm.nih.gov/pubmed/21908768
http://dx.doi.org/10.1093/jnci/djr319

Ejemplares similares